Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.49 |
| ▸ | MAOA | P21397 | 4/20 | 0.44 |
| ▸ | TTR | P02766 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10227386 | 0.86 | AHR (0.53) | AHRMAOATTRKDM4ECYP1A2 | |
| SCHEMBL14295772 | 0.82 | AHR (0.50) | AHRMAOATTRKDM4ECYP1A2 | |
| SCHEMBL24449222 | 0.81 | AHR (0.42) | AHRMAOATTRKDM4ECYP1A2 | |
| SCHEMBL22185971 | 0.80 | AHR (0.41) | AHRMAOATTRKDM4ECYP1A2 | |
| SCHEMBL12811238 | 0.79 | AHR (0.47) | AHRMAOATTRKDM4ECYP1A2 | |
| SCHEMBL16283915 | 0.79 | AHR (0.47) | AHRMAOAKDM4ECYP1A2MEN1 | |
| SCHEMBL25517145 | 0.79 | MAOB (0.41) | AHRKDM4ECYP1A2MEN1KMT2A | |
| SCHEMBL25517167 | 0.79 | MAPT (0.41) | AHRKDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL11976508 | 0.79 | MAOB (0.35) | AHRMAOAKDM4ECYP1A2ALDH1A1 | |
| SCHEMBL13021646 | 0.78 | PGR (0.45) | AHRMAOAKDM4ECYP1A2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295449-A1 | COMPOSITION AND LIGHT EMITTING DEVICE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-21 | — | — | US | disclosed |
| US-11021568-B2 | Polymer compound and light emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-06-01 | — | — | US | disclosed |
| US-20210087330-A1 | POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2021-03-25 | — | — | US | disclosed |
| US-10290818-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-05-14 | — | — | US | disclosed |
| US-20170110673-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-04-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10290818-B2 | Organometallic compound and organic light-emitting device including the same | L1CAM, L3MBTL1, LEF1 | AHR 1313/4885MAOA 3008/4885TTR 1819/4885 |
| US-20170110673-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | L1CAM, L3MBTL1, LEF1 | AHR 1313/4885MAOA 3008/4885TTR 1819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.